FLAM
CSTL icon

First Light Asset Management’s Castle Biosciences CSTL Stock Holding History

First Light Asset Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-160,126
Closed -$2.2M – 76
2023
Q2 		$2.2M Sell
160,126
-1,492
-0.9% -$30.2K 0.17% 47
2023
Q1 		$3.67M Buy
161,618
+14
+0% +$342 0.33% 42
2022
Q4 		$3.8M Sell
161,604
-1,620
-1% -$37.6K 0.35% 40
2022
Q3 		$4.26M Buy
+163,224
New +$4.58M 0.43% 42

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Light Asset Management's CSTL Position: Q3 2023 in Review

First Light Asset Management sold out of Castle Biosciences (CSTL) in Q3 2023, closing a stake of 160,126 shares — an estimated $2.2M sold.

First Light Asset Management first reported a position in CSTL in Q3 2022 and held it in 4 quarters. The position peaked at $4.26M in Q3 2022. 135 funds tracked by Wall St. Rank hold CSTL as of Q3 2023.

  • First Light Asset Management reported no remaining Castle Biosciences position as of Q3 2023 after selling out during the quarter.
  • First Light Asset Management sold 160,126 Castle Biosciences shares in Q3 2023, an estimated $2.2M.
  • First Light Asset Management first reported a position in Castle Biosciences in Q3 2022 and held it in 4 quarters.
  • First Light Asset Management's Castle Biosciences position peaked at $4.26M in Q3 2022.
  • 135 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2023.

Based on First Light Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.